Jump to content

George Q. Daley: Difference between revisions

Add links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous edit
Content deleted Content added
VisualWikitext
per MOS
No edit summary
 
(30 intermediate revisions by 18 users not shown)
Line 1: Line 1:
{{Short description|Medical academic}}
{{Infobox person
{{Infobox person
| name = George Q. Daley
| name = George Q. Daley
| image =
| image = File:George Q. Daley.jpg
| caption = Daley at the [[Edmond J. Safra Center for Ethics]] in 2019
| caption =
| birth_place = Catskill, NY<ref name="nytimes">{{cite web | url=https://www.nytimes.com/1995/06/18/style/weddings-amy-edmondson-george-q-daley.html | title=WEDDINGS: Amy Edmondson, George Q Daley | publisher=New York Times | accessdate=31 July 2015}}</ref>
| birth_place = Catskill, New York, U.S.<ref name="nytimes">{{cite news | url=https://www.nytimes.com/1995/06/18/style/weddings-amy-edmondson-george-q-daley.html | title=WEDDINGS: Amy Edmondson, George Q Daley | work=New York Times | date=18 June 1995 | access-date=31 July 2015}}</ref>
| nationality = American
| nationality = American
| education = [[Harvard University]] ([[Bachelor of Arts|BA]], [[Doctor of Medicine|MD]])<br />[[Massachusetts Institute of Technology]] ([[Doctor of Philosophy|PhD]])
|alma_mater = {{plain list|
⚫
| spouse = [[Amy Edmondson]]<ref name="nytimes" />
*[[Harvard University]] <small>(B.A., M.D.)</small>
*[[Massachusetts Institute of Technology]] <small>(Ph.D.)</small>
}}
⚫
| spouse = Amy Edmondson<ref name="nytimes" />
}}
}}


'''George Q. Daley''', is the Dean of the Faculty of Medicine, Caroline Shields Walker Professor of Medicine, and Professor of Biological Chemistry and Molecular Pharmacology at [[Harvard Medical School]]. He was formerly the Robert A. Stranahan Professor of Pediatrics at Harvard Medical School, Director of the Stem Cell Transplantation Program at [[Boston Children’s Hospital]], and an investigator of the [[Howard Hughes Medical Institute]],<ref name="hhmi">Investigators, Howard Hughes Medical Institute [http://www.hhmi.org/research/investigators/daley_bio.html] Retrieved 2010-08-30.</ref> Associate Director of Children’s Stem Cell Program, a member of the Executive Committee of the Harvard Stem Cell Institute.<ref name="hsci">Principal Faculty, Harvard Stem Cell Institute [http://www.hsci.harvard.edu/node/700] Retrieved 2010-08-30.</ref> He is a past president of the International Society for Stem Cell Research (2007–2008).<ref name="isscr">Officers, Leadership, International Society for Stem Cell Research [http://www.isscr.org/leadership/board.cfm] Retrieved 2010-08-30.</ref>
'''George Quentin Daley'''<ref name="nytimes" /> is the Dean of the Faculty of Medicine, Caroline Shields Walker Professor of Medicine, and Professor of Biological Chemistry and Molecular Pharmacology at [[Harvard Medical School]]. He was formerly the Robert A. Stranahan Professor of Pediatrics at Harvard Medical School, Director of the Stem Cell Transplantation Program at [[Boston Children's Hospital]], and an investigator of the [[Howard Hughes Medical Institute]],<ref name="hhmi">Investigators, Howard Hughes Medical Institute [http://www.hhmi.org/research/investigators/daley_bio.html] Retrieved 2010-08-30.</ref> Associate Director of Children's Stem Cell Program, a member of the Executive Committee of the Harvard Stem Cell Institute.<ref name="hsci">Principal Faculty, Harvard Stem Cell Institute [http://www.hsci.harvard.edu/node/700] {{Webarchive|url=https://web.archive.org/web/20100630112701/http://www.hsci.harvard.edu/node/700|date=2010-06-30}} Retrieved 2010-08-30.</ref> He is a past president of the International Society for Stem Cell Research (2007–2008).<ref name="isscr">Officers, Leadership, International Society for Stem Cell Research [http://www.isscr.org/leadership/board.cfm] {{Webarchive|url=https://web.archive.org/web/20100912005717/http://www.isscr.org/leadership/board.cfm|date=2010-09-12}} Retrieved 2010-08-30.</ref>


==Early life and education==
==Early life and education==
Daley was born in [[Catskill, New York]].
Daley was born in [[Catskill, New York]].


Daley received his bachelor's degree ''magna cum laude'' from [[Harvard University]] (1982), a Ph.D. in [[biology]] from [[MIT]] (1989), and the M.D. from [[Harvard Medical School]], where he was only the twelfth individual in the school’s history to be awarded the degree summa cum laude (1991). He served as Chief Resident in Internal Medicine at the [[Massachusetts General Hospital]] and is currently a staff physician in Hematology/Oncology at [[Children's Hospital Boston]] and [[Dana Farber Cancer Institute]] in [[Boston]].<ref name="photobooks">Specialists, Children's Hospital Boston [http://children.photobooks.com/directory/profile.asp?dbase=main&setsize=5&last=daley&pict_id=0011780] Retrieved 2010-08-30.</ref>
Daley received his Bachelor of Arts ''magna cum laude'' from [[Harvard College]] (1982), his PhD in [[biology]] from [[MIT]] (1989), and his MD from [[Harvard Medical School]], where he was the twelfth individual in the school's history to be awarded the degree ''summa cum laude'' (1991). He served as Chief Resident in Internal Medicine at the [[Massachusetts General Hospital]] and is currently a staff physician in Hematology/Oncology at [[Boston Children's Hospital]] and [[Dana–Farber Cancer Institute]].<ref name="photobooks">Specialists, Children's Hospital Boston [http://children.photobooks.com/directory/profile.asp?dbase=main&setsize=5&last=daley&pict_id=0011780] {{Webarchive|url=https://web.archive.org/web/20110727021541/http://children.photobooks.com/directory/profile.asp?dbase=main&setsize=5&last=daley&pict_id=0011780|date=2011-07-27}} Retrieved 2010-08-30.</ref>


As a graduate student working with Nobelist Dr. [[David Baltimore]], Dr. Daley demonstrated that the [[BCR/ABL]] oncogene induces [[chronic myeloid leukemia]] (CML) in a mouse model,<ref name="DALEY">DALEY ''et al.'', SCIENCE 1990</ref> which validated BCR/ABL as a target for drug blockade and encouraged the development of [[imatinib]] (Gleevec; Novartis), a magic-bullet chemotherapy that induces remissions in virtually every CML patient. Daley’s recent studies have clarified mechanisms of Gleevec resistance and informed novel combination chemotherapeutic regimens.<ref name="stemcell"/>
As a graduate student working with Nobelist [[David Baltimore]], Daley demonstrated that the [[BCR/ABL]] oncogene induces [[chronic myeloid leukemia]] (CML) in a mouse model,<ref name="DALEY">DALEY ''et al.'', SCIENCE 1990</ref> which validated BCR/ABL as a target for drug blockade and encouraged the development of [[imatinib]] (Gleevec; Novartis), a magic-bullet chemotherapy that induces remissions in virtually every CML patient. Daley's studies have clarified mechanisms of Gleevec resistance and informed novel combination chemotherapeutic regimens.<ref name="stemcell"/>


==Research==
==Research==
Daley's research seeks to translate insights in [[stem cell]] biology into improved therapies for genetic and malignant diseases. His laboratory has pioneered human cell culture-based and murine models of human blood disease and cancer.<ref name="stemcell">Biography, Stem Cell Program Leadership, Children's Hospital Boston [http://stemcell.childrenshospital.org/about-us/leadership-faculty-staff/george-daley-md-phd] Retrieved 2010-08-30.</ref> Important research contributions from his laboratory include the creation of customized stem cells to treat genetic immune deficiency in a mouse model (together with [[Rudolf Jaenisch]]),<ref name="mouse">RIDEOUT ET AL, CELL 2002</ref> the differentiation of germ cells from embryonic stem cells (cited as a "Top Ten Breakthrough" by ''[[Science (journal)|Science]]'' in 2003),<ref name="nih">Biography, 2004 Recipients, NIH Director's Pioneer Award [http://nihroadmap.nih.gov/pioneer/Recipients04.aspx] Retrieved 2010-08-30.</ref><ref name="GEIJSEN">GEIJSEN ET AL., NATURE 2003/4</ref> the generation of disease-specific pluripotent stem cells by direct reprogramming of human fibroblasts (cited in the "Breakthrough of the Year" issue of ''Science'' magazine in 2008),<ref name="mpm">Bios, Team, MPM Capital [http://www.mpmcapital.com/team/team-detail/george-daley-bio] Retrieved 2010-08-30.</ref><ref name="PARK">PARK ET AL, CELL 2008</ref> and demonstration of the role of the RNA-binding protein Lin28 in cancer and metabolic disease.
Daley's research seeks to translate insights in [[stem cell]] biology into improved therapies for genetic and malignant diseases. His laboratory has pioneered human cell culture-based and murine models of human blood disease and cancer.<ref name="stemcell">Biography, Stem Cell Program Leadership, Children's Hospital Boston [http://stemcell.childrenshospital.org/about-us/leadership-faculty-staff/george-daley-md-phd] Retrieved 2010-08-30.</ref> Important research contributions from his laboratory include the creation of customized stem cells to treat genetic immune deficiency in a mouse model (together with [[Rudolf Jaenisch]]),<ref name="mouse">RIDEOUT ET AL, CELL 2002</ref> the differentiation of germ cells from embryonic stem cells (cited as a "Top Ten Breakthrough" by ''[[Science (journal)|Science]]'' in 2003),<ref name="nih">Biography, 2004 Recipients, NIH Director's Pioneer Award [http://nihroadmap.nih.gov/pioneer/Recipients04.aspx] {{Webarchive|url=https://web.archive.org/web/20100528050920/http://nihroadmap.nih.gov/pioneer/Recipients04.aspx|date=2010-05-28}} Retrieved 2010-08-30.</ref><ref name="GEIJSEN">GEIJSEN ET AL., NATURE 2003/4</ref> the generation of disease-specific pluripotent stem cells by direct reprogramming of human fibroblasts (cited in the "Breakthrough of the Year" issue of ''Science'' magazine in 2008),<ref name="mpm">Bios, Team, MPM Capital [http://www.mpmcapital.com/team/team-detail/george-daley-bio] {{Webarchive|url=https://web.archive.org/web/20101004025846/http://www.mpmcapital.com/team/team-detail/george-daley-bio|date=2010-10-04}} Retrieved 2010-08-30.</ref><ref name="PARK">PARK ET AL, CELL 2008</ref> and demonstration of the role of the RNA-binding protein Lin28 in cancer and metabolic disease.


He has been elected a fellow of the [[American Association for the Advancement of Science]] and the [[American Academy of Arts and Sciences]], and a member of the [[Institute of Medicine of the National Academies]], [[American Society for Clinical Investigation]], American Association of Physicians and American Pediatric Societies. Daley was an inaugural winner of the NIH Director’s Pioneer Award (2004), which provides a five-year unrestricted grant to pursue highly innovative research,<ref name="nih"/> and received the Judson Daland Prize from the [[American Philosophical Society]] for achievement in patient-oriented research,<ref name="aps">Recipients of the Judson Daland Prize, American Philosophical Society [http://www.amphilsoc.org/prizes/dalandistas] Retrieved 2010-08-30.</ref> the [[E. Mead Johnson Award]] from the [[American Pediatric Society]] for contributions to stem cell research,<ref name="spr">Member Information, Society for Pediatric Research [http://www.aps-spr.org/spr/Awards/EMJ.htm] Retrieved 2010-08-30.</ref> and the E. Donnall Thomas Prize from the [[American Society of Hematology]] for advances in induced pluripotent stem cell research, in addition to awards recognizing his contributions to medical research from the [[National Institutes of Health]],<ref name="nhlbi">Meet the Scientists, National Heart Lunch and Blood Institute, National Institutes of Health [http://www.nhlbi.nih.gov/recovery/researchers/index.php?id=267] Retrieved 2010-08-30.</ref> the New England Cancer Society, Harvard Medical School, and the Leukemia and Lymphoma Society of America.<ref name="hsci"/> In addition to funding by the NIH, Dr. Daley's research has been supported by the National Science Foundation, Defense Advanced Research Projects Agency, American Cancer Society, Edward Mallinckrodt Jr. Foundation, [[Burroughs Wellcome Fund]], Leukemia and Lymphoma Society of America, Roche Foundation for Anemia Research, [[Alex's Lemonade Stand Foundation|Alex's Lemonade Stand]], [[Ellison Medical Foundation]], and Doris Duke Medical Foundation.
He has been elected a fellow of the [[American Association for the Advancement of Science]] and the [[American Academy of Arts and Sciences]], and a member of the [[Institute of Medicine of the National Academies]], [[American Society for Clinical Investigation]], American Association of Physicians and American Pediatric Societies. Daley was an inaugural winner of the NIH Director's Pioneer Award (2004), which provides a five-year unrestricted grant to pursue highly innovative research,<ref name="nih"/> and received the Judson Daland Prize from the [[American Philosophical Society]] for achievement in patient-oriented research,<ref name="aps">Recipients of the Judson Daland Prize, American Philosophical Society [http://www.amphilsoc.org/prizes/dalandistas] Retrieved 2010-08-30.</ref> the [[E. Mead Johnson Award]] from the [[American Pediatric Society]] for contributions to stem cell research,<ref name="spr">Member Information, Society for Pediatric Research [http://www.aps-spr.org/spr/Awards/EMJ.htm] {{Webarchive|url=https://web.archive.org/web/20100822075701/http://www.aps-spr.org/SPR/Awards/EMJ.htm|date=2010-08-22}} Retrieved 2010-08-30.</ref> and the E. Donnall Thomas Prize from the [[American Society of Hematology]] for advances in induced pluripotent stem cell research, in addition to awards recognizing his contributions to medical research from the [[National Institutes of Health]],<ref name="nhlbi">Meet the Scientists, National Heart Lunch and Blood Institute, National Institutes of Health [http://www.nhlbi.nih.gov/recovery/researchers/index.php?id=267] Retrieved 2010-08-30.</ref> the New England Cancer Society, Harvard Medical School, and the Leukemia and Lymphoma Society of America.<ref name="hsci"/> In addition to funding by the NIH, Daley's research has been supported by the National Science Foundation, Defense Advanced Research Projects Agency, American Cancer Society, Edward Mallinckrodt Jr. Foundation, [[Burroughs Wellcome Fund]], Leukemia and Lymphoma Society of America, Roche Foundation for Anemia Research, [[Alex's Lemonade Stand Foundation|Alex's Lemonade Stand]], [[Ellison Medical Foundation]], and Doris Duke Medical Foundation.


Daley has been prominent in advocating for ethical oversight of human stem cell research. On behalf of the International Society for Stem Cell Research (ISSCR), he chaired the special international task force that formulated the ISSCR Guidelines for Human Embryonic Stem Cell Research (2006) and as president of the ISSCR empaneled and served on the special task force that wrote the ISSCR Guidelines for Clinical Translation of Stem Cells (2008),<ref name="isscrguidelines">Information for Scientists, ISSCR {{cite web|url=http://www.isscr.org/clinical_trans/index.cfm |title=Archived copy |accessdate=2010-09-02 |deadurl=yes |archiveurl=https://web.archive.org/web/20090603085208/http://www.isscr.org/clinical_trans/index.cfm |archivedate=2009-06-03 |df= }} Retrieved 2010-08-30.</ref> which have served as a roadmap for advancing stem cell science into clinical trials. Dr. Daley has testified six times before committees of the [[United States Senate]] and [[United States House of Representatives]] to advocate for expanded governmental support for stem cell research. He has served on the scientific advisory board of the Massachusetts Life Sciences Center and on the editorial board of the journals ''Science, Cell, Cell Stem Cell, Stem Cells, and Blood''.<ref name="stemcell"/>
Daley has been prominent in advocating for ethical oversight of human stem cell research. On behalf of the International Society for Stem Cell Research (ISSCR), he chaired the special international task force that formulated the ISSCR Guidelines for Human Embryonic Stem Cell Research (2006) and as president of the ISSCR empaneled and served on the special task force that wrote the ISSCR Guidelines for Clinical Translation of Stem Cells (2008),<ref name="isscrguidelines">Information for Scientists, ISSCR {{cite web|url=http://www.isscr.org/clinical_trans/index.cfm |title=ISSCR :: Scientists : Information for Scientists |access-date=2010-09-02 |url-status=dead |archive-url=https://web.archive.org/web/20090603085208/http://www.isscr.org/clinical_trans/index.cfm |archive-date=2009-06-03 }} Retrieved 2010-08-30.</ref> which have served as a roadmap for advancing stem cell science into clinical trials. Daley has testified six times before committees of the [[United States Senate]] and [[United States House of Representatives]] to advocate for expanded governmental support for stem cell research. He has served on the scientific advisory board of the Massachusetts Life Sciences Center and on the editorial board of the journals ''Science'', ''Cell'', ''Cell Stem Cell'', ''Stem Cells'', and ''Blood''.<ref name="stemcell"/>


==References==
==References==
{{Scholia|author}}
{{Scholia|author}}
{{Reflist}}
{{Reflist}}{{HMS Deans}}{{Authority control}}

{{Authority control}}


{{DEFAULTSORT:Daley, George Q.}}
{{DEFAULTSORT:Daley, George Q.}}
[[Category:Scientists from New York (state)]]
[[Category:Scientists from New York (state)]]
[[Category:Harvard Medical School alumni]]
[[Category:Harvard Medical School alumni]]
[[Category:Massachusetts Institute of Technology alumni]]
[[Category:Massachusetts Institute of Technology School of Science alumni]]
[[Category:Harvard Medical School faculty]]
[[Category:Harvard Medical School faculty]]
[[Category:Living people]]
[[Category:Living people]]
Line 44: Line 40:
[[Category:Year of birth missing (living people)]]
[[Category:Year of birth missing (living people)]]
[[Category:Place of birth missing (living people)]]
[[Category:Place of birth missing (living people)]]
[[Category:People from Boston]]
[[Category:Academics from Boston]]
[[Category:Fellows of the AACR Academy]]
[[Category:Fellows of the AACR Academy]]
[[Category:Members of the National Academy of Medicine]]

Latest revision as of 16:41, 28 October 2024

George Q. Daley
Daley at the Edmond J. Safra Center for Ethics in 2019
Born
Catskill, New York, U.S.[1]
NationalityAmerican
EducationHarvard University (BA, MD)
Massachusetts Institute of Technology (PhD)
SpouseAmy Edmondson[1]

George Quentin Daley[1] is the Dean of the Faculty of Medicine, Caroline Shields Walker Professor of Medicine, and Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. He was formerly the Robert A. Stranahan Professor of Pediatrics at Harvard Medical School, Director of the Stem Cell Transplantation Program at Boston Children's Hospital, and an investigator of the Howard Hughes Medical Institute,[2] Associate Director of Children's Stem Cell Program, a member of the Executive Committee of the Harvard Stem Cell Institute.[3] He is a past president of the International Society for Stem Cell Research (2007–2008).[4]

Early life and education

[edit]

Daley was born in Catskill, New York.

Daley received his Bachelor of Arts magna cum laude from Harvard College (1982), his PhD in biology from MIT (1989), and his MD from Harvard Medical School, where he was the twelfth individual in the school's history to be awarded the degree summa cum laude (1991). He served as Chief Resident in Internal Medicine at the Massachusetts General Hospital and is currently a staff physician in Hematology/Oncology at Boston Children's Hospital and Dana–Farber Cancer Institute.[5]

As a graduate student working with Nobelist David Baltimore, Daley demonstrated that the BCR/ABL oncogene induces chronic myeloid leukemia (CML) in a mouse model,[6] which validated BCR/ABL as a target for drug blockade and encouraged the development of imatinib (Gleevec; Novartis), a magic-bullet chemotherapy that induces remissions in virtually every CML patient. Daley's studies have clarified mechanisms of Gleevec resistance and informed novel combination chemotherapeutic regimens.[7]

Research

[edit]

Daley's research seeks to translate insights in stem cell biology into improved therapies for genetic and malignant diseases. His laboratory has pioneered human cell culture-based and murine models of human blood disease and cancer.[7] Important research contributions from his laboratory include the creation of customized stem cells to treat genetic immune deficiency in a mouse model (together with Rudolf Jaenisch),[8] the differentiation of germ cells from embryonic stem cells (cited as a "Top Ten Breakthrough" by Science in 2003),[9][10] the generation of disease-specific pluripotent stem cells by direct reprogramming of human fibroblasts (cited in the "Breakthrough of the Year" issue of Science magazine in 2008),[11][12] and demonstration of the role of the RNA-binding protein Lin28 in cancer and metabolic disease.

He has been elected a fellow of the American Association for the Advancement of Science and the American Academy of Arts and Sciences, and a member of the Institute of Medicine of the National Academies, American Society for Clinical Investigation, American Association of Physicians and American Pediatric Societies. Daley was an inaugural winner of the NIH Director's Pioneer Award (2004), which provides a five-year unrestricted grant to pursue highly innovative research,[9] and received the Judson Daland Prize from the American Philosophical Society for achievement in patient-oriented research,[13] the E. Mead Johnson Award from the American Pediatric Society for contributions to stem cell research,[14] and the E. Donnall Thomas Prize from the American Society of Hematology for advances in induced pluripotent stem cell research, in addition to awards recognizing his contributions to medical research from the National Institutes of Health,[15] the New England Cancer Society, Harvard Medical School, and the Leukemia and Lymphoma Society of America.[3] In addition to funding by the NIH, Daley's research has been supported by the National Science Foundation, Defense Advanced Research Projects Agency, American Cancer Society, Edward Mallinckrodt Jr. Foundation, Burroughs Wellcome Fund, Leukemia and Lymphoma Society of America, Roche Foundation for Anemia Research, Alex's Lemonade Stand, Ellison Medical Foundation, and Doris Duke Medical Foundation.

Daley has been prominent in advocating for ethical oversight of human stem cell research. On behalf of the International Society for Stem Cell Research (ISSCR), he chaired the special international task force that formulated the ISSCR Guidelines for Human Embryonic Stem Cell Research (2006) and as president of the ISSCR empaneled and served on the special task force that wrote the ISSCR Guidelines for Clinical Translation of Stem Cells (2008),[16] which have served as a roadmap for advancing stem cell science into clinical trials. Daley has testified six times before committees of the United States Senate and United States House of Representatives to advocate for expanded governmental support for stem cell research. He has served on the scientific advisory board of the Massachusetts Life Sciences Center and on the editorial board of the journals Science, Cell, Cell Stem Cell, Stem Cells, and Blood.[7]

References

[edit]
Scholia has an author profile for George Q. Daley.
  1. ^ a b c "WEDDINGS: Amy Edmondson, George Q Daley". New York Times. 18 June 1995. Retrieved 31 July 2015.
  2. ^ Investigators, Howard Hughes Medical Institute [1] Retrieved 2010-08-30.
  3. ^ a b Principal Faculty, Harvard Stem Cell Institute [2] Archived 2010-06-30 at the Wayback Machine Retrieved 2010-08-30.
  4. ^ Officers, Leadership, International Society for Stem Cell Research [3] Archived 2010-09-12 at the Wayback Machine Retrieved 2010-08-30.
  5. ^ Specialists, Children's Hospital Boston [4] Archived 2011-07-27 at the Wayback Machine Retrieved 2010-08-30.
  6. ^ DALEY et al., SCIENCE 1990
  7. ^ a b c Biography, Stem Cell Program Leadership, Children's Hospital Boston [5] Retrieved 2010-08-30.
  8. ^ RIDEOUT ET AL, CELL 2002
  9. ^ a b Biography, 2004 Recipients, NIH Director's Pioneer Award [6] Archived 2010-05-28 at the Wayback Machine Retrieved 2010-08-30.
  10. ^ GEIJSEN ET AL., NATURE 2003/4
  11. ^ Bios, Team, MPM Capital [7] Archived 2010-10-04 at the Wayback Machine Retrieved 2010-08-30.
  12. ^ PARK ET AL, CELL 2008
  13. ^ Recipients of the Judson Daland Prize, American Philosophical Society [8] Retrieved 2010-08-30.
  14. ^ Member Information, Society for Pediatric Research [9] Archived 2010-08-22 at the Wayback Machine Retrieved 2010-08-30.
  15. ^ Meet the Scientists, National Heart Lunch and Blood Institute, National Institutes of Health [10] Retrieved 2010-08-30.
  16. ^ Information for Scientists, ISSCR "ISSCR :: Scientists : Information for Scientists". Archived from the original on 2009-06-03. Retrieved 2010-09-02. Retrieved 2010-08-30.
Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=George_Q._Daley&oldid=1253931331"